Sort   by:  
 Page size 
UnknownGlycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Not available
S-EPMC9065180 | biostudies-literature
ProteomicsN-linked glycosylation of the M-protein variable region: Glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma.
Multiple Myeloma (MM) is a plasma cell malignancy characterized by a monoclonal expansion of plasma cells that secrete a characteristic M-protein. This M-protein is crucial for diagnosis and monitoring of MM in the blood of patients. Recent evidence has emerged that N-glycosylation of the M-protein ...
ORGANISM(S): Homo sapiens (Human) 
2023-06-09 | PXD040718 | Pride
Glycoproteomics Glycoproteogenomics M-protein Multiple myeloma 
UnknownGlycoproteogenomics: A Frequent Gene Polymorphism Affects the Glycosylation Pattern of the Human Serum Fetuin/α-2-HS-Glycoprotein.
Not available
S-EPMC6683009 | biostudies-literature
ProteomicsCharacterization of CD44s glycoproteoforms in bladder tumours and bladder cancer cell culture models
Bladder cancer (BC) is a major health concern retaining high mortality rates when diagnosed at advanced stages. In this context, the clinical management of BC requires the introduction of new biomarkers and molecular targets capable to elicit precision medicine therapeutical approaches. A promising ...
ORGANISM(S): Homo sapiens (Human) 
2022-05-19 | PXD028307 | Pride
Glycosylation Cd44 Glycoproteogenomics Bladder cancer Alternative splicing 
UnknownGlycoproteogenomics: Setting the Course for Next-generation Cancer Neoantigen Discovery for Cancer Vaccines.
Not available
S-EPMC8498922 | biostudies-literature
ProteomicsAnalysis of human fetuin peptides originating from the serum of individuals, part 2
Human fetuin, also known as α-2-HS glycoprotein, is an abundant glycoprotein circulating in human plasma. AHSG is the gene symbol responsible for coding the fetuin protein. A frequent polymorphism of AHSG results in two alleles, AHSG*1 and AHSG*2, which producing three genotypes (AHSG*1, AHSG*2, and...
ORGANISM(S): Homo sapiens (Human) 
2019-05-20 | PXD012465 | Pride
Human O-glycosylation Gene polymorphism N-glycosylation Phosphorylation Glycopeptides Fetuin 
ProteomicsTargeting N-linked Glycosylation for the Therapy of Human Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer with two major biological subtypes, activated B-cell like (ABC) and germinal center B-cell-like (GCB) DLCBL. Self-antigen engagement of B-cell receptors (BCRs) in ABC tumors promotes their clustering in the plasma membrane, thereby initi...
ORGANISM(S): Homo sapiens (Human) 
2023-04-22 | PXD036363 | Pride
B cell receptor Functional glycoproteomics Nf-kb Phosphoproteomics Lymphoma Dlbcl 
ProteomicsTargeting N-linked Glycosylation for the Therapy 1 of Aggressive Lymphomas
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer with two major biological subtypes, activated B-cell like (ABC) and germinal center B-cell-like (GCB) DLCBL. Self-antigen engagement of B-cell receptors (BCRs) in ABC tumors promotes their clustering in the plasma membrane, thereby initi...
ORGANISM(S): Homo sapiens (Human) 
2023-04-24 | PXD038951 | Pride
Glycosylation Dlbcl Lc-ms/ms 
Sort   by:  
 Page size